Litcius/Paper detail

Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in mice

Jiahuan Li, Xiaoling Deng, Tao Bai, Shuhan Wang, Qianqian Jiang, Keshu Xu

2020International Immunopharmacology53 citationsDOI

Topics & Concepts

SteatohepatitisSteatosisTLR4Oxidative stressPharmacologyInflammationChemistryLipopolysaccharideFatty liverLiver injuryEndocrinologyBiologyInternal medicineMedicineImmunologyBiochemistryDiseaseFatty Acid Research and HealthLiver Disease Diagnosis and TreatmentNatural Products and Biological Research
Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in mice | Litcius